Td Asset Management Inc Senti Biosciences, Inc. Transaction History

Td Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$0.41 - $0.99 $46,400 - $112,040	113,172 Added 88.39%	241,208 $98,000
Q2 2023 Aug 09, 2023	BUY	$0.6 - $1.14 $5,846 - $11,108	9,744 Added 8.24%	128,036 $80,000
Q4 2022 Feb 06, 2023	SELL	$1.25 - $65.2 $20,750 - $1.08 Million	-16,600 Reduced 12.31%	118,292 $166,000
Q3 2022 Nov 07, 2022	BUY	$1.33 - $21.7 $62,770 - $1.02 Million	47,196 Added 53.82%	134,892 $285,000
Q2 2022 Aug 04, 2022	BUY	$1.97 - $10.0 $172,761 - $876,960	87,696 New	87,696 $172,000

342K

Ticker SNTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,757,100
Market Cap $172M
Description
Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antig...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.